Benzonaphthyridine
    23.
    发明授权
    Benzonaphthyridine 失效
    苯并萘啶

    公开(公告)号:US06384047B1

    公开(公告)日:2002-05-07

    申请号:US09424841

    申请日:1999-12-03

    IPC分类号: C07D47104

    CPC分类号: C07D471/04

    摘要: Compounds 8,9-diethoxy-2-methyl-6-[4(p-toluenesulfonamide) phenyl]-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and 9-ethoxy-8-methoxy-2-methyl-6-[4-(p-toluenesulfonamido)phenyl]-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and medicament compositions based thereon are useful for treating airway disorders, high blood pressure disorders and concomitant disorders connected therewith.

    摘要翻译: 化合物8,9-二乙氧基-2-甲基-6- [4(对甲苯磺酰胺)苯基] -1,2,3,4,4a,10b-六氢苯并[c] [1,6]萘啶和9-乙氧基 - 8-甲氧基-2-甲基-6- [4-(对甲苯磺酰氨基)苯基] -1,2,3,4,4a,10b-六氢苯并[c] [1,6]萘啶及其基础上的药物组合物是有用的 用于治疗气道障碍,高血压障碍和与之相关的伴随疾病。

    N-oxides
    28.
    发明授权
    N-oxides 失效
    N-氧化物

    公开(公告)号:US06306869B1

    公开(公告)日:2001-10-23

    申请号:US09673649

    申请日:2000-11-01

    申请人: Dieter Flockerzi

    发明人: Dieter Flockerzi

    IPC分类号: C07D47104

    CPC分类号: C07D471/04

    摘要: N-oxides of formula 1 wherein R1, R2, R3 and R4 have the meanings given in the description, are selective inhibitors of types 3 and 4 of cyclic nucleotide phosphodiesterase (PDE3, PDE4); they are useful on the one hand as bronchial therapeutics but on the other hand especially for the treatment of disorders of inflammatory nature.

    摘要翻译: R1,R2,R3和R4具有本说明书中给出的含义的式1的N-氧化物是环核苷酸磷酸二酯酶(PDE3,PDE4)的3型和4型的选择性抑制剂; 它们一方面作为支气管理学有用,但另一方面尤其用于治疗炎症性疾病。